Patent Cases High Court May Review: Part 2
Richard de Bodo
Amy M. Dudash In this two-part article, we are reviewing the pending petitions for certiorari at the U.S. Supreme Court that are most likely to impact life sciences companies. In part 1, we discussed the petitions filed by Sequenom Inc. (patent ineligibility), Life Technologies Corp. (§ 271(f)(1)), and WesternGeco LLC (reasonable royalties). In part 2 of this article, we discuss the remaining petitions that will most likely impact the life sciences industry, and comment on the likely outcome of each petition....
To view the full article, register now.